These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30980714)

  • 1. Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis.
    Khan N; Vallarino C; Lissoos T; Darr U; Luo M
    Inflamm Bowel Dis; 2020 Feb; 26(3):462-468. PubMed ID: 30980714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Khan N; Vallarino C; Lissoos T; Darr U; Luo M
    Drugs Aging; 2017 Nov; 34(11):859-868. PubMed ID: 29170864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients.
    de Jong ME; Smits LJT; van Ruijven B; den Broeder N; Russel MGVM; Römkens TEH; West RL; Jansen JM; Hoentjen F
    J Crohns Colitis; 2020 Jul; 14(7):888-895. PubMed ID: 31974546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
    Kirchgesner J; Lemaitre M; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
    Gastroenterology; 2018 Aug; 155(2):337-346.e10. PubMed ID: 29655835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases.
    Singh S; Heien HC; Sangaralingham L; Shah ND; Sandborn WJ
    Clin Transl Gastroenterol; 2021 Jul; 12(7):e00380. PubMed ID: 34228004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after Arthroplasty.
    Gregory MH; McKinnon A; Stwalley D; Hippensteel KJ; Loftus EV; Ciorba MA; Olsen MA; Deepak P
    J Crohns Colitis; 2019 Feb; 13(2):182-188. PubMed ID: 30256926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of pneumonia among patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
    Gregory MH; Ciorba MA; Wiitala WL; Stidham RW; Higgins P; Morley SC; Hou JK; Feagins LA; Govani SM; Cohen-Mekelburg SA; Waljee AK
    Inflamm Bowel Dis; 2020 May; 26(6):919-925. PubMed ID: 31504531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
    Lee WJ; Lee TA; Calip GS; Suda KJ; Briars L; Schumock GT
    Inflamm Bowel Dis; 2018 Mar; 24(4):883-891. PubMed ID: 29562275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
    Kariyawasam VC; Kim S; Mourad FH; Selinger CP; Katelaris PH; Brian Jones D; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Pathirana PW; Leong RW
    Inflamm Bowel Dis; 2019 Jul; 25(8):1390-1398. PubMed ID: 30597066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Kochar B; Cai W; Cagan A; Ananthakrishnan AN
    Gastroenterology; 2020 Jun; 158(8):2104-2111.e2. PubMed ID: 32105728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.
    Cotter TG; Gathaiya N; Catania J; Loftus EV; Tremaine WJ; Baddour LM; Harmsen WS; Zinsmeister AR; Sandborn WJ; Limper AH; Pardi DS
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):850-856. PubMed ID: 28013116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease.
    Andersson P; Karling P
    Ups J Med Sci; 2022; 127():. PubMed ID: 35140875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014.
    Ludvigsson JF; Mahl M; Sachs MC; Björk J; Michaelsson K; Ekbom A; Askling J; Backman AS; Olén O
    Am J Gastroenterol; 2019 Feb; 114(2):291-304. PubMed ID: 30730858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.
    Pugliese D; Guidi L; Ferraro PM; Marzo M; Felice C; Celleno L; Landi R; Andrisani G; Pizzolante F; De Vitis I; Papa A; Rapaccini GL; Armuzzi A
    Aliment Pharmacol Ther; 2015 Oct; 42(7):880-8. PubMed ID: 26235565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Biologic Agents for the Management of Inflammatory Bowel Disease After Liver Transplantation.
    Shaikh SA; Fitzgerald L; Tischer S
    Pharmacotherapy; 2017 Dec; 37(12):1578-1585. PubMed ID: 28960437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study.
    Bozon A; Nancey S; Serrero M; Caillo L; Gilletta C; Benezech A; Combes R; Danan G; Akouete S; Pages L; Bourgaux JF; Le Cosquer G; Boivineau L; Meszaros M; Altwegg R
    Clin Res Hepatol Gastroenterol; 2023 May; 47(5):102107. PubMed ID: 36906225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease.
    Gong SS; Fan YH; Han QQ; Lv B; Xu Y
    World J Gastroenterol; 2019 May; 25(18):2240-2250. PubMed ID: 31143074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.